Lucido Louis C.'s Form 4 filing
BioCorRx Inc. (BICX) · filed Oct 25, 2021
- Accession no.
- 0001477932-21-007564
- Filed
- Oct 25, 2021
- Trade date
- Sep 30-Oct 19, 2021
- Filing delay
- 25 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $4.96K. It was filed 25 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lucido Louis C.CIK 0001539788 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2021 | Common Stock, par value $0.001 | AGrant or awardAcquired | +1,381 | $0.00 | $0 | 68,536 | Direct | |
| Oct 19, 2021 | Common Stock, par value $0.001 | PPurchaseAcquired | +1,550 | $3.20 | +$4,960 | 70,806 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.